Resurgence of human coronavirus OC43 at a long-term care facility during the coronavirus disease 2019 (COVID-19) pandemic: Outbreak investigation.

Autor:	Ohyama K; Department of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan., Honda H; Department of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan., Aoki M; Social Welfare Corporation IKOI, Kuwana, Mie, Japan.; Aoki Memorial Hospital, Kuwana, Mie, Japan., Wakuda M; Department of Laboratory Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan., Kitahara T; Department of Laboratory Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan., Kaede C; Department of Laboratory Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan., Doi Y; Department of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States., Uehara Y; Department of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Jazyk:	angličtina
Zdroj:	Antimicrobial stewardship & healthcare epidemiology : ASHE [Antimicrob Steward Healthc Epidemiol] 2023 Jun 05; Vol. 3 (1), pp. e97. Date of Electronic Publication: 2023 Jun 05 (Print Publication: 2023).
DOI:	10.1017/ash.2023.172
Abstrakt:	The incidence of seasonal infections due to respiratory viruses other than severe acute respiratory coronavirus virus 2 (SARS-CoV-2) has declined due to heightened public infection prevention measures against coronavirus disease 2019 (COVID-19). We describe an outbreak of human coronavirus OC43 infection that occurred at a long-term care facility and whose clinical features were indistinguishable from COVID-19. Competing Interests: Y.D. has served on advisory boards for Gilead, GSK, Moderna, MSD, Shionogi, Meiji Seika, received honorarium from Gilead, Shionogi, bioMérieux, and received research funding from Entasis and Shionogi. H.H. received honorarium from Moderna and bioMérieux, and the Institut Mérieux-JAID Award in 2019. (© The Author(s) 2023.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu